RxDoctor Payments Data

Dillon Miller, MD

Family Medicine · Raleigh, NCNPI 1619199056

Payments from drug & device makers

$1,986in general payments, 2019–2025

Across 133 payments — averaging $14.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$374
  • Novo Nordisk$276
  • Lilly USA, LLC$230
  • Pfizer$218
  • Amgen$204
  • AbbVie$110
  • plus $574 from 18 others

What the payments were for

  • Food & beverage$1,980100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,986 in reported general payments places this provider in the 75th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$3,749
Medicare patients
19
Services billed
51

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin64$58,658
MounjaroTirzepatide32$53,806
XareltoRivaroxaban54$45,039
OzempicSemaglutide29$37,812
EliquisApixaban46$31,320
JanuviaSitagliptin Phosphate28$27,223
TrulicityDulaglutide21$25,209
FarxigaDapagliflozin Propanediol12$18,323
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$12,670
Atorvastatin Calcium382$2,358
Albuterol Sulfate HfaAlbuterol Sulfate84$2,270
Gabapentin123$1,961
Lidocaine20$1,256
Rosuvastatin Calcium148$1,055
Diclofenac Sodium23$842

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$230$79,01453 claims
Johnson & JohnsonXarelto$56$45,03954 claims
Novo NordiskOzempic$276$37,81229 claims
PfizerEliquis$218$31,32046 claims
MerckJanuvia$51$27,22328 claims
AstraZenecaFarxiga$374$18,32312 claims
GSKTrelegy Ellipta$12$12,67017 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →